Barclays’s Invacare Corporation IVC Stock Holding History

Barclays’s Portfolio IVC Stock Details IVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-43,000	Closed	-$18.1K	–	5543
2022 Q4	$18.1K	Sell	43,000 -5,153	-11%	-$2.77K	﹤0.01%	4826
2022 Q3	$38K	Sell	48,153 -4,584	-9%	-$4.82K	﹤0.01%	3865
2022 Q2	$67K	Buy	52,737 +37,535	+247%	+$49.4K	﹤0.01%	3936
2022 Q1	$21K	Sell	15,202 -25,650	-63%	-$54.9K	﹤0.01%	4431
2021 Q4	$111K	Buy	40,852 +13,440	+49%	+$49.5K	﹤0.01%	3708
2021 Q3	$130K	Buy	27,412 +9,270	+51%	+$67.7K	﹤0.01%	3804
2021 Q2	$146K	Sell	18,142 -24,510	-57%	-$204K	﹤0.01%	3686
2021 Q1	$342K	Buy	42,652 +4,681	+12%	+$43.6K	﹤0.01%	3426
2020 Q4	$340K	Sell	37,971 -3,636	-9%	-$30.2K	﹤0.01%	3480
2020 Q3	$313K	Buy	41,607 +10,525	+34%	+$73K	﹤0.01%	3551
2020 Q2	$197K	Buy	31,082 +3,121	+11%	+$20.9K	﹤0.01%	4080
2020 Q1	$209K	Sell	27,961 -36,590	-57%	-$284K	﹤0.01%	4260
2019 Q4	$582K	Sell	64,551 -173,662	-73%	-$1.46M	﹤0.01%	4168
2019 Q3	$1.79M	Buy	238,213 +197,912	+491%	+$1.11M	﹤0.01%	3010
2019 Q2	$210K	Buy	40,301 +6,185	+18%	+$40.3K	﹤0.01%	5059
2019 Q1	$285K	Buy	34,116 +20,447	+150%	+$147K	﹤0.01%	4559
2018 Q4	$59K	Sell	13,669 -43,157	-76%	-$381K	﹤0.01%	5387
2018 Q3	$827K	Buy	56,826 +7,386	+15%	+$122K	﹤0.01%	3817
2018 Q2	$919K	Sell	49,440 -8,898	-15%	-$161K	﹤0.01%	3375
2018 Q1	$1.01M	Buy	58,338 +25,273	+76%	+$446K	﹤0.01%	3199
2017 Q4	$557K	Buy	33,065 +32,257	+3,992%	+$525K	﹤0.01%	3701
2017 Q3	$13K	Sell	808 -10,651	-93%	-$152K	﹤0.01%	6020
2017 Q2	$151K	Buy	11,459 +6,125	+115%	+$80.5K	﹤0.01%	4600
2017 Q1	$63K	Buy	5,334 +3,090	+138%	+$37K	﹤0.01%	5199
2016 Q4	$30K	Buy	2,244 +1,564	+230%	+$18K	﹤0.01%	5436
2016 Q3	$8K	Sell	680 -3,842	-85%	-$46.2K	﹤0.01%	5880
2016 Q2	$55K	Buy	4,522 +1,202	+36%	+$14.2K	﹤0.01%	4778
2016 Q1	$43K	Buy	3,320 +3,253	+4,855%	+$46.1K	﹤0.01%	4862
2015 Q4	$1K	Sell	67 -136	-67%	-$2.46K	﹤0.01%	5882
2015 Q3	$2K	Sell	203 -3,155	-94%	-$55.2K	﹤0.01%	6400
2015 Q2	$71K	Buy	3,358 +2,391	+247%	+$50.6K	﹤0.01%	4922
2015 Q1	$19K	Sell	967 -6,986	-88%	-$121K	﹤0.01%	5874
2014 Q4	$127K	Sell	7,953 -9,329	-54%	-$142K	﹤0.01%	4996
2014 Q3	$191K	Sell	17,282 -9,922	-36%	-$151K	﹤0.01%	4785
2014 Q2	$489K	Sell	27,204 -17,194	-39%	-$292K	﹤0.01%	4007
2014 Q1	$844K	Sell	44,398 -12,381	-22%	-$255K	﹤0.01%	3418
2013 Q4	$1.3M	Buy	56,779 +14,752	+35%	+$305K	﹤0.01%	3097
2013 Q3	$714K	Sell	42,027 -982	-2%	-$15.6K	﹤0.01%	3715
2013 Q2	$617K	Buy	+43,009	New	+$596K	﹤0.01%	3969

Other funds holding IVC

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

IIM

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

WFA

Wellspring Financial Advisors Cleveland, Ohio $1.33B AUM 21.85% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Barclays's IVC Position: Q1 2023 in Review

Barclays sold out of Invacare Corporation (IVC) in Q1 2023, closing a stake of 43,000 shares — an estimated $18.1K sold.

Barclays first reported a position in IVC in Q2 2013 and held it in 39 quarters. The position peaked at $1.79M in Q3 2019. 10 funds tracked by Wall St. Rank hold IVC as of Q1 2023.

Barclays reported no remaining Invacare Corporation position as of Q1 2023 after selling out during the quarter.
Barclays sold 43,000 Invacare Corporation shares in Q1 2023, an estimated $18.1K.
Barclays first reported a position in Invacare Corporation in Q2 2013 and held it in 39 quarters.
Barclays's Invacare Corporation position peaked at $1.79M in Q3 2019.
10 funds tracked by Wall St. Rank held Invacare Corporation as of Q1 2023.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.